Allergies News and Research

Latest Allergies News and Research

Household bleach decontaminates stainless steel wires coated with CWD prions

A 5-minute soak in a 40% solution of household bleach decontaminated stainless steel wires coated with chronic wasting disease (CWD) prions, according to a new study by National Institutes of Health scientists.

5 Oct 2019

New defensive mechanism against bacterial wound infections discovered

Wound inflammation which results in impaired wound healing can have serious consequences for patients. Researchers from Charité - Universitätsmedizin Berlin have discovered a new defensive mechanism which enables our skin to actively kill bacteria.

4 Oct 2019

Fewer than half of U.S. adults get annual flu shot, shows study

So far this calendar year, 1,243 people scattered around 31 states had confirmed measles, the highest number of measles cases reported in the U.S.

3 Oct 2019

Study assesses treatment options in African Americans with poorly controlled asthma

A new study of African Americans with poorly controlled asthma, found differences in patients' responses to commonly used treatments. Contrary to what researchers had expected, almost half of young children in the study responded differently than older children and adults, and than white children in prior studies.

1 Oct 2019

Study: Transmission of protozoan parasite may cause leishmaniasis-like symptoms in people

A new study published this week online in Emerging Infectious Diseases suggests that transmission of a protozoan parasite from insects may also cause leishmaniasis-like symptoms in people

1 Oct 2019

US Government to fund development of a 'universal flu vaccine'

The US government is to provide up to 400 million USD in funding to develop a “universal” flu vaccination at Duke University over the next seven years.

1 Oct 2019

Brazilian researchers identify new species of parasite in fatal case of visceral leishmaniasis

Brazilian researchers believe they have identified in patients treated at the University Hospital (HU) in Aracaju, state of Sergipe, a new species of parasite that can cause a disease similar to visceral leishmaniasis but is resistant to the treatments currently available.

1 Oct 2019

Mount Sinai researchers receive NIH award to develop universal flu vaccine

Researchers at the Icahn School of Medicine at Mount Sinai have received a contract award of up to $132 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), as part of a new Collaborative Influenza Vaccine Innovation Centers (CIVICs) program to further develop the universal flu vaccine.

1 Oct 2019

NIAID initiates new Collaborative Influenza Vaccine Innovation Centers program

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has initiated the Collaborative Influenza Vaccine Innovation Centers program, a new network of research centers that will work together in a coordinated, multidisciplinary effort to develop more durable, broadly protective and longer-lasting influenza vaccines.

30 Sep 2019

Uncovering new treatment targets for pulmonary inflammation in sickle cell disease

A new study by De, Agrawal, Morrone et al, challenges the common notion that airway inflammation in Sickle Cell Disease (SCD) is secondary to asthma, even though the two disorders often coexist.

30 Sep 2019

Duke Human Vaccine Institute participates in a large national effort to improve flu shots

As part of a massive national effort to improve and modernize flu shots, the Duke Human Vaccine Institute has received three research contracts from the National Institute of Allergy and Infectious Diseases, with an initial award of approximately $29.6 million in first-year funding.

30 Sep 2019

Study: Heart disease is associated with allopurinol-related severe skin reactions

Heart disease is an independent risk factor for severe adverse skin reactions in patients taking allopurinol, found a study published in CMAJ (Canadian Medical Association Journal).

30 Sep 2019

NAU researchers aim to find microbial link between two common respiratory diseases

Asthma and chronic rhinosinusitis- sinus inflammation that lasts for at least three months- are serious and costly diseases, and both are on the rise. According to the American Academy of Allergy, Asthma and Immunology, CRS affects up to 16 percent of the U.S. adult population and eats up a staggering 5 percent of the country's health care budget each year.

27 Sep 2019

NIH awards $30 million to accelerate progress in TB vaccine development

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded $30 million in first-year funding to establish new centers for immunology research to accelerate progress in tuberculosis vaccine development.

26 Sep 2019

New NIH program aims to improve lives for people with inherited blood and immune diseases

People with inherited diseases of the blood and immune system can now receive treatment at the National Institutes of Health Clinical Center through a new, streamlined program that integrates expertise from many medical specialties and related basic science disciplines.

26 Sep 2019

Prediction system found to be effective at increasing palliative care consultations

Palliative Connect, a trigger system developed at Penn Medicine and powered by predictive analytics, was found to be effective at increasing palliative care consultations for seriously ill patients, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.

25 Sep 2019

Only half of patients with sinus, throat, or ear infections receive first-line antibiotics

Investigators have now shown that only half of patients presenting with sinus, throat, or ear infections at different treatment centers received the recommended first-line antibiotics, well below the industry standard of 80 percent.

25 Sep 2019

GlobalData: First peanut allergy therapy unlikely to be a good choice for all patients

The FDA’s Allergenic Products Advisory Committee gave Palforzia a resounding vote of confidence and GlobalData believes that the committee’s strong support for Palforzia, despite its imperfections, highlights just how extreme the level of unmet need has become within the peanut allergy space.

25 Sep 2019

As off-label use spreads, supplies of niche drugs and patients’ patience grow short

Medical treatment has knocked down tumors in 6-year-old Easton Daniels' brain, but the drug used also wiped out his immune system.

24 Sep 2019

Transperineal prostate biopsy minimizes risk of infection, may increase detection rate

Loyola Medicine is among the first centers to offer a new minimally invasive prostate biopsy that minimizes the risk of infection and may increase the cancer detection rate.

24 Sep 2019

Allergies News and Research

Latest Allergies News and Research

Household bleach decontaminates stainless steel wires coated with CWD prions

New defensive mechanism against bacterial wound infections discovered

Fewer than half of U.S. adults get annual flu shot, shows study

Study assesses treatment options in African Americans with poorly controlled asthma

Study: Transmission of protozoan parasite may cause leishmaniasis-like symptoms in people

US Government to fund development of a 'universal flu vaccine'

Brazilian researchers identify new species of parasite in fatal case of visceral leishmaniasis

Mount Sinai researchers receive NIH award to develop universal flu vaccine

NIAID initiates new Collaborative Influenza Vaccine Innovation Centers program

Uncovering new treatment targets for pulmonary inflammation in sickle cell disease

Duke Human Vaccine Institute participates in a large national effort to improve flu shots

Study: Heart disease is associated with allopurinol-related severe skin reactions

NAU researchers aim to find microbial link between two common respiratory diseases

NIH awards $30 million to accelerate progress in TB vaccine development

New NIH program aims to improve lives for people with inherited blood and immune diseases

Prediction system found to be effective at increasing palliative care consultations

Only half of patients with sinus, throat, or ear infections receive first-line antibiotics

GlobalData: First peanut allergy therapy unlikely to be a good choice for all patients

As off-label use spreads, supplies of niche drugs and patients’ patience grow short

Transperineal prostate biopsy minimizes risk of infection, may increase detection rate

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in